A coalescence of available scientific evidence and new regulatory possibilities is creating opportunities for local innovation in addressing obesity. One promising example stems from the menu-labeling provisions of the Affordable Care Act.
No takes yet. Share an insight, caveat, or question.
Bleich et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: